Trexquant Investment’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.04M Sell
364,981
-120,077
-25% -$753K 0.01% 1245
2026
Q2
$2.76M Buy
485,058
+463,499
+2,150% +$2.27M 0.02% 1050
2026
Q1
$92.5K Sell
21,559
-165,328
-88% -$921K ﹤0.01% 1707
2025
Q4
$1.67M Buy
+186,887
New +$1.16M 0.01% 1048
2022
Q2
– Sell
-44,032
Closed -$232K – 1750
2022
Q1
$232K Buy
44,032
+19,556
+80% +$110K 0.01% 1134
2021
Q4
$208K Buy
+24,476
New +$225K 0.01% 1128
2021
Q3
– Sell
-22,873
Closed -$213K – 1374
2021
Q2
$213K Buy
+22,873
New +$261K 0.02% 884

Other funds holding NUVB

Trexquant Investment's NUVB Position: Q3 2026 in Review

Trexquant Investment reduced its Nuvation Bio (NUVB) stake by 25% in Q3 2026, selling an estimated $753K and leaving 364,981 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #1245.

Trexquant Investment first reported a position in NUVB in Q2 2021 and has held it in 7 quarters since. The position peaked at $2.76M in Q2 2026. 259 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Trexquant Investment held 364,981 shares of Nuvation Bio worth $2.04M as of Q3 2026.
  • Trexquant Investment sold 120,077 Nuvation Bio shares in Q3 2026, an estimated $753K.
  • Nuvation Bio made up 0.01% of Trexquant Investment's portfolio in Q3 2026, its #1245 holding.
  • Trexquant Investment first reported a position in Nuvation Bio in Q2 2021 and has held it in 7 quarters since.
  • Trexquant Investment's Nuvation Bio position peaked at $2.76M in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.